Zobrazeno 1 - 10
of 673
pro vyhledávání: '"WEI Guoqing"'
Publikováno v:
发电技术, Vol 44, Iss 3, Pp 296-304 (2023)
With the gradual increase in the proportion of new energy, energy storage technology, as an auxiliary new energy grid, has attracted wide attention. Hydrogen energy storage and fuel cell technology have been listed as strategic energy technologies in
Externí odkaz:
https://doaj.org/article/838c1a8bc955454fbc36a02a05db31f8
Publikováno v:
Translational Neuroscience, Vol 12, Iss 1, Pp 561-572 (2021)
Hypoxic–ischemic brain damage (HIBD) is a major cause of brain injury in neonates. Bone marrow mesenchymal stem cells (BMSCs) show therapeutic potential for HIBD, and genetic modification may enhance their neuroprotective effects. The goal of this
Externí odkaz:
https://doaj.org/article/15487ad094254feea64b4e29ae490e8e
Publikováno v:
In International Journal of Refractory Metals and Hard Materials November 2024 124
Autor:
Wei, Guoqing, Zhang, Qi, Liu, Xuepeng, Zhang, Yifan, Meng, Xuan, Li, Haixin, Li, Zhipeng, Luo, Laima, Wu, Yucheng
Publikováno v:
In Materials Characterization August 2024 214
Publikováno v:
In Polymer Degradation and Stability March 2024 221
Publikováno v:
In Engineering Structures 1 March 2024 302
Autor:
Li, Chunjian, Sun, Pengdong, Wei, Guoqing, Zhu, Yuqi, Li, Jingyuan, Liu, Yanfeng, Chen, Jian, Deng, Yang
Publikováno v:
In Synthetic and Systems Biotechnology March 2024 9(1):99-107
Publikováno v:
Experimental Hematology & Oncology, Vol 1, Iss 1, p 36 (2012)
Abstract The human CD19 antigen is a 95 kd transmembrane glycoprotein belonging to the immunoglobulin superfamily. CD19 is classified as a type I transmembrane protein, with a single transmembrane domain, a cytoplasmic C-terminus, and extracellular N
Externí odkaz:
https://doaj.org/article/2759a6aea60d43e484d064abc5dc6f41
Publikováno v:
Experimental Hematology & Oncology, Vol 1, Iss 1, p 10 (2012)
Abstract Background Liposomal formulations of anthracyclines appear to have favorable toxicity profile when compared with conventional anthracyclines in elderly, high risk cardiac patients and patients with prior use of anthracyclines. Randomized con
Externí odkaz:
https://doaj.org/article/2577e6858cdf410c8597d309baf08da4
Publikováno v:
Experimental Hematology & Oncology, Vol 1, Iss 1, p 3 (2012)
Externí odkaz:
https://doaj.org/article/34e786b628c6428fb8e0fcca0278adef